DermTech shareholders approve doubling authorized shares and expanding equity incentive plan

DermTech, Inc.

Authorized common stock increased from 50M to 100M shares; approved by 20.6M votes for, 2.3M against.
2020 equity plan evergreen raised from 3.5% to 5% of outstanding shares annually, extended through FY2030.
Nathalie Gerschtein Keraudy elected as Class III director until 2026; board size reduced to seven.
Proposal to add officer exculpation under Delaware law failed; KPMG LLP ratified as auditor.
Plan amendment allows up to 75M shares for ISOs; aggregate grant cap for non-employee directors set at $600K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

DermTech, Inc.: The company filed an amendment to its certificate of incorporation to increase authorized shares of common stock from 50,000,000 to 100,000,000 (effective 2023-06-02).

Change: charter amendment
Effective: 2023-06-02

Exact text from the filing

On June 2, 2023, the Company filed an amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase the authorized number of shares of common stock of the Company from 50,000,000 to 100,000,000 shares (the “Amended Certificate”).

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

DermTech, Inc. shareholders approved Amendment to the DermTech, Inc. 2020 Equity Incentive Plan to Modify the Plan’s Evergreen Provision at the 2023-05-31 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-05-31

Exact text from the filing

The Plan Amendment was approved by the Company’s stockholders at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 31, 2023

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

DermTech, Inc. shareholders voted on Election of Directors at the 2023-05-31 meeting.

Proposal: director election
Meeting: 2023-05-31

Exact text from the filing

The Plan Amendment was approved by the Company’s stockholders at the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 31, 2023, the results of which are reported below in Item 5.07

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001651944-23-000060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.